Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry

by Emma Gray, David J. Pasta, Suzanne Norris, Aisling O’Leary, on behalf of the Irish Hepatitis C Outcomes and Research Network (ICORN)
Published 2017-04-01

The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease Inhibitors.

by Linh Thuy Nguyen, Emma Gray, Aisling O'Leary, Michael Carr, Cillian F De Gascun, Irish Hepatitis C Outcomes Research Network
Published 2016-01-01

Introduction and utilisation of high priced HCV medicines across Europe; implications for the future

by Winnie de Bruijn, Cristina Ibáñez, Pia Frisk, Hanne Bak Pedersen, Ali Alkan, Patricia Vella Bonanno, Ljiljana Sović Brkičić, Anna Bucsics, Guillame Dedet, Jaran Eriksen, Joseph O Fadare, Jurij Fürst, Gisselle Gallego, Isabella Piassi Godói, Isabella Piassi Godói, Augusto Afonso Guerra Junior, Augusto Afonso Guerra Junior, Hakki Gürsöz, Saira Jan, Saira Jan, Jan Jones, Saim Kerman, Roberta Joppi, Ott Laius, Newman Madzikwa, Einar Magnusson, Mojca Maticic, Vanda Markovic-Pekovic, Vanda Markovic-Pekovic, Amos Massele, Olayinka Ogunleye, Olayinka Ogunleye, Aisling O’Leary, Jutta Piessnegger, Catherine Sermet, Steven Simoens, Celda Tiroyakgosi, Ilse Truter, Magnus Thyberg, Kristina Tomekova, Magdalene Wladysiuk, Sortiris Vandoros, Elif Hilal Vural, Corinne Zara, Brian Godman, Brian Godman
Published 2016-07-01